Agenda
Challenges for Modern Medicine
Remote Diagnostics, AI (Artificial Intelligence), DL (Deep Learning) as Answers
Healthnomic – the Company Offering Remote Diagnostics of Civilization Diseases
Healthnomic – Resources
Why Do We Start with Telemedicine Diagnostics?
Plans for 2021
Future
02
Civilization
Diseases
increased the number of people suffering from obesity since 1975
04
Projected number of deaths caused by cardiovascular diseases
in 2017-2030 (M people)
17,90
23,70
Source: Heart Disease and Stroke Statistics — 2018 Update, American Heart
CAGR:
2.2%
2019 20243 times
39%
5,7%
people over the age of 18 suffered from obesity in 2016
of the adult population suffered from
COVID-19 Pandemic
Since 2019, the dynamic spread of the coronavirus causing the COVID-19 disease has begun.
Over 51 million people have contracted the disease worldwide, and the number is growing
rapidly.
SARS-CoV-2 and similar pathogens pose a threat to life, especially for the elderly and those with
chronic diseases.
The pandemic has shown that health systems are overburdened and there is a shortage of
medical personnel.
Therefore, we observe the need for automation, digitization and development of remote
services in order to increase the efficiency of the system and to relieve it.
Humanity is exposed to further pandemics, which is why it is a great opportunity for
the development of telemedicine solutions and companies implementing new technologies in
medicine.
Thanks to the dissemination of such solutions, it will be possible to reduce the risk of
infection with the coronavirus and similar pathogens by people whose life and health are
particularly at risk.
Challenges Facing Medicine
06
The pandemic showed that health systems are overburdened and there is a shortage of physicians. In
addition, civilization diseases in combination with the coronavirus increase the risk of serious symptoms
during infection. Demographic changes
As a result of the challenges facing
medicine, it appeared the demand
for professional medical entities
offering both diagnostics as well as
conducting the full treatment
process remotely using modern
technology.
COVID-19 diseasepandemic
Cardiovascular diseases and cancer are the most common cause of death in the world. According to WHO, nearly 24 million people worldwide may die of
cardiovascular disease in 2030. Increase in the number of deaths as a result of civilization diseases
In 2017, the world’s population aged 60 and above was 962 million, and by 2050 it is expected to increase to
Cardiovascular diseases and cancer which are the most common cause of death in the
world
Demographic changes
COVID-19 pandemic and future epidemiological
crises.
Artificial Intelligence, AI
Deep Learning, DL
The answer is comprehensive telemedicine systems using
technologies such as: The modern medical
market is facing a number of challenges
2,24
17,02
Projected value of the global market for AI solutions in medicine in 2019-2024 (USD billion)
Source: The Artificial Intelligence in Medicine Market Growth, Trends and Forecasts, mordorintelligence.com
40,02%
CAGR:
Projected value of the global market for DL solutions in 2017-2023 (USD billion)
2,28
18,16
Source: Deep Learning Market by Offering - Global Forecast to 2023 , Markets and Markets
41,7%
CAGR:
2019 2024
2017 2023
In the near future, the popularity of AI/DL technology in medicine will
grow dynamically.
The vast majority of diagnostic solutions available in Poland use technologies from over
10 years ago.
Healthnomic - the Company Offering
Diagnostics of Civilization Diseases
11
Professional medical entity offering:
1. Remote diagnostics and treatment of civilization diseases, 2. Development and integration of a proprietary telemedicine
platform in various diagnostic models.
Diagnostics Treatment Development and integration of OmniHealth environment Obstructive Sleep Apnea Cardiovascular
diseases CPAP, EPAP
New, innovative treatment methods Own systems development Integration with external systems COPD patient monitoring Cardiovascular patient monitoring
CEO, Founder
Dariusz Głogowski, MD, MBA
A graduate of the Faculty of Medicine at the Medical University of Łódź and MBA studies at the University of Denver, Colorado. Experienced senior manager and business leader with extensive experience in the pharmaceutical industry. Walked the path from the representative to the General Manager in Polish and
international companies. Managed the companies Alvogen Poland and Alvogen EU Cluster, Farma-Projekt,
PharmaSwiss Poland.
Team
13
Head of Medical Department
Aleksandra Jarecka-Dobroń, MD, PhD
Internal medicine specialist, in 2019 she defended her PhD thesis on Obstructive Sleep Apnea and related arrhythmias with distinction. In Healthnomic is handling medical
consulting in the field of ongoing and planned projects, analysis and description of examinations. Consults physicians and patients with results of carried out examinations.
Head of Customer Support Department Ewa Puchalska, MA, BEng
Obtained a master’s degree in engineering at the Faculty of Mechatronics of the Warsaw University of Technology, graduating in Biomedical Engineering, Medical Apparatus major. Responsible for contact with foreign business partners and for polish partner clinic supporting. Before joining Healthnomic, worked in the international trading company Magnesia GmbH in Germany.
Head of Service and Device Development Department Piotr Różalski, MA, BEng
A graduate of the Electronics Faculty at the Warsaw University of Technology, Electronics and Computer Science in Medicine major. Responsible for the production and proper operation of devices offered by Healthnomic and supervises new products development.
Head of Software Development Department Aleksander Cudny, MA, BEng
A graduate of Biomedical Engineering at the Faculty of Mechatronics of the Warsaw University of Technology. Handling the development of algorithms using Deep Learning and Artificial Intelligence technologies. Has been involved in professional software development for 5 years, especially in Python. Before joining our company worked at the European Center for Nuclear Research CERN in Geneva.
Scientific
Council
14
Krzysztof J. Filipiak, MD, PhD
Physician, academic teacher, cardiology, internal medicine, hypertensiology and clinical pharmacology specialist, former vice-rector of the Medical University of Warsaw, chairman of the Medical Sciences Discipline Council of the Medical University of Warsaw, past president of the Polish Society of Hypertension.
Robert Pływaczewski , MD, PhD
Physician, academic teacher, professor of the Tuberculosis and Lung Diseases Institute in Warsaw, internal diseases and lung diseases specialist, chairman of the Breathing
Disorders in Sleep section of the Polish Society of Lung Diseases, head of the Sleep Laboratory at Tuberculosis and Lung Diseases Institute in Warsaw.
Agnieszka Mastalerz-Migas, MD, PhD Physician, academic teacher, family medicine specialist, head of the Family Medicine Department at the Medical
University of Wroclaw, president of the Polish Family Medicine Society, national consultant in the field of family medicine.
Known
Customers
15
240
facilitiesover
2,2 M
patientsover
2 000
facilities over0,7 M
patientsWe are in commercial cooperation with the companies above. We're reaching out to new partners.
Healthnomic’s Resources
16
Medicine and pharmacy – sales, marketing, reimbursement, support from themedical society, enterprise management
Know-how in the field of telemedicine and medical data processing Experience in implementing cloud medical systems
Lung Diseases, Cardiology, Family Medicine Biomedical engineering
Computer Science – use in medical devices
Management of public companies, fund raising
Szef Działu Rozwoju Oprogramowania
mgr inż. Aleksander Cudny
Absolwent Inżynierii Biomedycznej na Wydziale Mechatroniki
Politechniki Warszawskiej. Zajmuje się opracowywaniem algorytmów wykorzystujących technologie Deep Learning oraz Artificial Intelligence. Od 5 lat zajmuje się profesjonalnym rozwojem oprogramowania,
szczególnie w języku Python.
Przed rozpoczęciem pracy w naszej firmie, pracował w Europejskim Centrum Badań Jądrowych CERN w Genewie.
Scalability of the solution – a system capable of handling thousands of tests performed
simultaneously
Cutting edge user interfaces
Lowers the operational cost, while maintaining high efficiency and service quality
Multi-lingual, easily translatable system
Innovative Telemedical System
06
17
18
Time saving for doctors and patients thanks to examination and diagnostics automation
Easy to add brand new medical technologies
Lower costs without comprimising quality
More space for doctor – patient relation building
Cloud solutions integration
Easy to buy equipment and/ or subscribe services
06
Healthnomic Environment — Algorithms
19
Algorithms OSA
initial signals filtering detecting body position changes, abdomen and chest
movements
detecting saturation drops detecting dyspnea and apnea, indicating the types of the above
detecting snoring episodes
HRV analysis
detection of heart rythm and conduction disorders artifacts detection – in progress
QT analysis – in progress initial signals filtering
indication and classification of QRS complex
detection of ventricular and supraventricular arythmias
and atrial fibrillation
The aim of Healthnomic is to create an integrated platform for remote diagnostics.
In the II and III stage, the company plans to cooperate with external partners offering
telemedicine systems. Then, the universal platform will be established, offering the tools to
remotely monitor patients well being and smartly coordinate the disease management process.
Healthnomic platform OmniHealth
06
20
External systems System No N04
Automated diagnostics
Development of DL and AI technologies algorithms will limit the workload for doctors and technicians
Artificial Intelligence
Systems that mimic human cognition on task assignments, can improve
their effectiveness on the basis of gathered experience.
Deep Learning
Process when the computer is learning how to perform
tasks natural for human brains like the speech
recogniition, picture identification or forecast
generating.
Own Algorithms Development
21
Rozwój własnych
algorytmów
Why Do We Start with
Why Do We Manage Obstructive Sleep Apnea
(OSA)?
Very common disorder – 4-7% (exactly like type 2 diabetes) of adults population, more often men, circa 2,6 M patients in Poland, oftenly undiagnosed
The most important risk factor – obesity, age
The most important complications: hypertension, traffic accidents, depression, potency disorders, ischemic heart disease, sudden death
Hospital polisomnography – annual max capacity 20-30 k. patients
Outpatient poligraphy as good as hospital polisomnography at majority of patients Standard CPAP treatment often poorly tolerated by patients
Very low OSA recognition among doctors Very low OSA recognition in the society
24
OSA — OUR BUSINESS MODEL
We educate doctors with multimedia remote courses Education will enable promotion of our solution
For individual doctors - out-patient OSA diagnostics as a service ordered by doctor for the patient - model BtC For out-patient clinics - purchase our equipment and subscribe to our services - model BtB
We propose well tolerated EPAP treatment (currently not present in Poland), effective in majority of patients Additionally we propose CPAP tratment
We have a well checked medical device, we are preparing also a brand new device We have an access to the net of medical representatives
In the II stage we will propose out-patient OSA diagnostics as a service ordered directly by the patient Additionally we will propose EPAP treatment purchase directly by the patient
Implementation depends only on problem recognition growth in the society
We will introduce 2 similar business models in partnering countries, where we are searching for distributors
OSA — OUR BUSINESS MODEL
Planned
Revenue Sources 2021
26
OSA diagnostics as a service.
Promotion to doctors. Sales of services and equipment. Promotion to out-patients clinic.
EPAP sales. Monitoring disease. Management effects.
COPD patient monitoring. Holter-ECG.
B2C
B2B
Foreign Expansion 2021
27
Because HEALTHNOMIC solutions brings breakthrough value worldwide we are
planning promotion of our services abroad.
We are planning to participate in international congressess
Medica, Dusseldorf
Strategic Aims 2021
28
Above20 000
Circa2 000
Above2 000
30
OSA tests performed untill the end of 2021
doctors we are planning to cooperate with untill the end of 2021
medical devices we are planning to use untill the end of 2021
medical representatives will offer cooperation to doctors and
out-patient clinics
Planned Platform Development Directions
30
ApneaHealth CardioHealth
Holter-ECG further development. Implementation of detection and monitoring of patients with heart
diseases and stroke risk. Full hospital polisomnography
with detection of EEG and sleep cycles.
Works in progress both on moduls and algorithms.
Neuro systems diagnostics enabling analysis of EEG/ EMG/
EOG.
NeuroHealth PulmoHealth
COPD patients monitoring. Early detection of exacerbation of the disease
Monitoring of disease management and
Patients Telemedicine Environment CardioHealth NeuroHealth ApneaHealth ECG diagnstics ... Equipment data Data
Results Orders Diagnosis Patients and tests data
Test data + patients data Diagnosis Patients cards + tests orders Reports External platforms P1 Platform Hospital and other systems Clinics Remote diagnostics equipment
OmniHealth Platform Potential
...
31
Modules for test description Diagnostic modul AI
Myocardial infarcion visualisation - 3D model Clinics data Administration moduls Tests results PulmoHealth Tests orders
Remote Diagnostics and Disease Management
We can manage every field of medicine where there is a need for remote diagnostics We have ready to use education model for health care professionals (HCPs)
We closely cooperate with medical society
We use OmniHealth platform which can be easily adapted to other fields of medicine We have ready to use business models
We have many years of experience and lots of enthusiasm and we are eager to work hard to achieve results
"Development Accelator" Model in Medicine
We search for interesting projects and to support authors
Authors are very often not familiar with financial and commercial aspects of ventures We offer business models and help with commercialization
We educate HCP, medical representatives and gain support from Opinion Leaders We are planning to create entities and lead them to stock exchange debut
We have all necessary people, tools and experience on board
